Clinical Trial Update: Gemcitabine Plus Ascorbate for Sarcoma in Adults (Pilot) [EARLY_Phase 1]

View source ↗

Summary

Early-phase 1 clinical trial evaluating gemcitabine plus high-dose ascorbate for sarcoma in adults is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Sarcoma
• Bone Tumor
• Sarcoma
• Soft Tissue Sarcoma
• Unresectable Soft Tissue Sarcoma

Drugs mentioned

• Ascorbate (ascorbate)
• Gemzar (gemcitabine)

Snippet

Sponsor: University of Iowa | Conditions: Sarcoma, Soft Tissue Sarcoma | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING